Rosetta Genomics To Present Multiple Posters At The 44th Annual Meeting Of The American Society Of Clinical Oncology (ASCO)
Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced that it will present multiple posters at the upcoming ASCO annual meeting in Chicago. The company also has three publication only abstracts available on ASCO’s website. The event will take place from May 30 to June 3 at the McCormick Place, Chicago, Illinois. Presented posters: 1.
More: continued here
Filed under: Cancer on May 17th, 2008